Catamaran, a provider of technology and PBM services, has acquired Salveo Specialty Pharmacy for $260 million in cash, which represents a TTM EBITDA multiple of approximately 13x. Salveo manages approximately $400 million in annual drug spend through its FL headquarters, as well as its NY (Echo Salveo Specialty Pharmacy) and CA (Mission Road Pharmacy) operations.
Market Pulse transactions shown herein are provided as a matter of public record. These transactions have been compiled from press releases, corporate announcements and other public sources to provide an overview of acquisition and merger activities within the healthcare and life sciences sectors.